Ireland: Legal Landscape Struggles To Keep Pace With The Rise Of Telemedicine

Last Updated: 13 July 2016
Article by Colin Kavanagh, Orla Keane, Ciara Farrell and Olivia Mullooly
Most Read Contributor in Ireland, December 2017

Telemedicine encompasses a wide variety of services such as teleconsultation, telemonitoring and telesurgery. Telemedicine can also include remote consultation/e-visits or video conferences between health professionals and can be delivered through various forms of IT systems including mobile phone apps.

It is this complexity in delivery that causes headaches for the legal landscape due to the interplay between the regulation of healthcare services, medical devices, intellectual property and data protection when offering telemedicine services.


The nature and scope of telemedicine can be somewhat difficult to define. At present, most European Union Member States have not adopted legal instruments specifically regulating telemedicine, including Ireland. Therefore, there is no legal definition of telemedicine in Ireland. The European Commission defines telemedicine as "the provision of healthcare services, through the use of ICT, in situations where the health professional and the patient (or two health professionals) are not in the same location. It involves secure transmission of medical data and information, through text, sound, images or other forms needed for the prevention, diagnosis, treatment and follow-up of patients".1 The Irish Health Service Executive and the Department of Health have published similar definitions.2

It is worth noting that phrases such as "telemedicine" "eHealth", "telehealth", "telecare", and "connected health" are all used interchangeably in this context. This has only added to the uncertainty surrounding the scope and nature of telemedicine services.


It is well established that telemedicine is a service and as such falls under the provisions of the Treaty on the Functioning of the European Union (i.e. Article 56 – freedom to provide services). This includes the freedom for citizens to receive health services from another Member State, regardless of how the service is delivered, i.e. through telemedicine.

Directive 2011/24/EU which was transposed in Ireland by the European Union (Application of Patients' Rights in Cross-Border Healthcare) Regulations 2015 endorses the right that all EU citizens are entitled to receive health services from another Member State, regardless of how the service is delivered, i.e. through telemedicine. The 2015 Regulations came into operation in Ireland on 1 June 2014.

Patients have the right to be reimbursed for the provision of cross-border health services, which includes cross-border telemedicine services. However, reimbursement will occur only if the telemedicine service falls within the range of healthcare services to which citizens are entitled in the Member State of affiliation. Ireland is the Member State of affiliation for persons insured in Ireland who are receiving medical treatment in another country.

Additionally, cross-border healthcare is to be provided in accordance with the legislation of the Member State of treatment. For the purposes of the 2015 Regulations, the provision of telemedicine is considered to have taken place in the Member State in which the healthcare provider is established.

One issue that arises in this regard is the recognition of professional qualifications. In Ireland, the Medical Practitioners Act, 2007 (as amended) requires all medical practitioners practicing in Ireland to be on the register maintained by the Medical Council of Ireland. However, according to the Directive and the 2015 Regulations, a healthcare provider providing treatment outside Ireland to patients in Ireland is considered to be providing medical treatment in the Member State in which he or she is established. As such, the medical practitioner would not need to be registered with the Medical Council, as he or she would not be providing treatment in Ireland.


The provision of telemedicine services may also evoke the application of the EU medical devices legislation, namely Directive 93/42/EEC, Directive 98/79/ EEC and Directive 90/385/EEC. This is due to the fact that manufacturers of mobile health applications and devices that support telemedicine services must comply with multiple, and often conflicting, regulatory requirements promulgated by various regulatory authorities.

Qualification of a device or software as a medical device can trigger a number of related regulatory requirements. These include conducting clinical investigations on the device, undergoing a conformity assessment procedure and CE marking the device.

Software embedded or incorporated into medical hardware (e.g. software that controls a CT scanner) is deemed to be a medical device as it is an integral part of the medical device. By contrast, "standalone software" such as medical health apps will be considered a medical device only if it has a "medical purpose". Pursuant to Directive 93/42/EEC, standalone software has a "medical purpose" if it is intended by the manufacturer to be used for the purposes of:

"diagnosis, prevention, monitoring, treatment or alleviation of disease;

diagnosis, monitoring, treatment, alleviation of, or compensation for, an injury or handicap;

investigation, replacement or modification of the anatomy or of a physiological process; or

control of conception."

The information in the instructions for use, labelling and promotional materials related to the device is important when determining the manufacturer's intended purpose.

Software that monitors a patient and collects information entered by the user, measured automatically by the app or collected by a point of care device may qualify as a medical device if the output affects the treatment of an individual. On the other hand, software that provides general information but does not provide personalised advice, although it may be targeted to a particular user group, is unlikely to be considered a medical device.

Manufacturers should consult the various guidelines issued by the regulatory authorities (including the Irish Health Products Regulatory Authority and the European Commission) on the qualification and classification of standalone software to see if your software is in fact a medical device or an in vitro diagnostic device.


The processing of personal data, including personal health data, is governed by the Data Protection Directive 95/46/EC, which is transposed in Ireland through the Data Protection Acts 1988 and 2003. The processing of sensitive information such as health information is subject to stricter requirements than other types of personal data.

Directive 95/46/EC does not define health data. However, according to the Article 29 Working Party, which includes representatives of the national data protection authorities in the EU, health data is not only data which is inherently or clearly medical data, but also includes raw sensor data which can be used in combination with other data to draw conclusions about the health status or risk of a person, irrespective of whether these conclusions are inaccurate, illegitimate or inadequate. Thus, while an app that tracks an individual's steps during a given day may not provide significant substance with regard to a person's health, it may provide information on a health condition when analysed in combination with other relevant personal information.

The processing of health data is prohibited unless it can meet one of the permitted exemptions in Directive 95/46/EC, which includes obtaining the explicit consent of the relevant individual. There are also other requirements beyond the need to obtain consent. All personal data must be processed fairly and lawfully and collected solely for specified, explicit and legitimate purposes. Appropriate technical and organisational measures must be implemented to ensure the security and confidentiality of the data.

It should be noted that the new EU General Data Protection Regulation ("GDPR") will replace the existing Directive 95/45/EC, with a more harmonised approach to data protection across the EU. As a regulation, the GDPR will be directly applicable in the member states, without the need for any implementing legislation.

The new safeguards adopted by the regulation will include the obligation on controllers to introduce data protection by design and default into their processing systems. They will also be obliged to produce a data protection impact assessment ("DPIA") where proposed data processing is likely to result in a high risk to the rights and freedoms of individuals. It is important to note that a DPIA is not mandatory when doctors or healthcare professionals process health data concerning their patients. Additionally, the Irish Data Protection Commissioner is permitted to publish a list of processing operations that do not require a DPIA. Many organisations using health data may, therefore, need to carry out DPIAs before processing personal health data.


While telemedicine has obvious benefits such as improving patient care and healthcare system efficiency, a fragmented legal landscape which involves compliance with the various different legal regimes discussed above could hinder such benefits.

Companies offering telemedicine services must keep this in mind and take a holistic approach when navigating the relevant legal and regulatory requirements. Getting the key players involved at this early stage will also help identify any gaps in assessment. As telemedicine is a moving target, companies should also keep a dialogue with the relevant regulatory authorities to confirm whether the authorities are drafting or preparing any guidance that might be relevant.


1 Communication on telemedicine for the ben­efit of patients, healthcare systems and society, COM(2008)689

2 eHealth Strategy for Ireland

This article contains a general summary of developments and is not a complete or definitive statement of the law. Specific legal advice should be obtained where appropriate.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:
  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.
  • Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.
    If you do not want us to provide your name and email address you may opt out by clicking here
    If you do not wish to receive any future announcements of products and services offered by Mondaq you may opt out by clicking here

    Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

    Use of

    You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


    Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

    The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


    Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

    • To allow you to personalize the Mondaq websites you are visiting.
    • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
    • To produce demographic feedback for our information providers who provide information free for your use.

    Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

    Information Collection and Use

    We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

    We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

    Mondaq News Alerts

    In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


    A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

    Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

    Log Files

    We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


    This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

    Surveys & Contests

    From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


    If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


    From time to time Mondaq may send you emails promoting Mondaq services including new services. You may opt out of receiving such emails by clicking below.

    *** If you do not wish to receive any future announcements of services offered by Mondaq you may opt out by clicking here .


    This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

    Correcting/Updating Personal Information

    If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

    Notification of Changes

    If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

    How to contact Mondaq

    You can contact us with comments or queries at

    If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.

    By clicking Register you state you have read and agree to our Terms and Conditions